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Abstract: A retrospective review of 982 patients treated for basal cell carcinoma (BCC) 
was conducted over a period of 8 years from 1996 to 2004. Of these patients, 16 presented a 
margin involvement. Two cohorts of patients with involved margin were identiﬁ  ed: the group 
whose basal cell carcinoma was re-excised, and the “wait and see” group. Both sets of results 
obtained were compared, and then matched with recent international literature reviews. Re-
excision is our current practice for incompletely excised tumor. However during the period 
examined only 36 patients of 116 with margin involvement, proceeded to re-excision, and of 
the remaining 80 patients just 39 were followed-up. The others were missed mainly because 
of the difﬁ  culty of attending follow-up consultations because of advanced age, poor general 
conditions, and unavailability of transport facilities. On the basis of several points, including a 
high number of residual tumors detected in the re-excised patients, and difﬁ  culty in maintaining 
diligent follow-up in the “wait and see” group, we stress the importance of considering an early 
re-excision in case of margin involvement (focal, lateral, or deep), to avoid a signiﬁ  cant risk 
of recurrence. In this study 16 patients out of 39 in the “wait and see” group had recurrences 
over 8 years of follow-up; a signiﬁ  cant number of recurrences was observed after 5 years. We 
therefore reserve a clinical follow-up only for patients in whom poor general health dissuades 
us from re-operation.
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Introduction
Although the basal cell carcinoma is one of the most common lesion treated by the 
plastic surgeon, there is a quantitative argument in the literature, about the correct 
treatment of the incompletely excised tumor.
Those favoring the “wait and see” method pointed out that only a minority of 
patients will develop recurrent disease and, if follow-up is diligent, supplementary 
treatment at that stage will keep the disease under control (Gooding et al 1965; Casson 
1980; Huynh and Veness 2002; Wilson et al 2004; Wettstein et al 2006; Rogalski 
et al 2007).
Those favoring immediate re-excision considered any recurrence rate unacceptable, 
and thus the need for more radical surgery to control recurrent disease (Shanoff et al 
1967; Koplin and Zarem 1980).
The purpose of this study is to compare the outcomes obtained by re-excision of the 
lesions with those of the “wait and see” group, as well as to match both these results 
with statistical data from the international literature.
Materials and methods
In our department, cases treated for basal cell carcinoma over a period of 8 years from 
1996 to 2004 were analyzed. We compared the outcomes obtained by re-excision of the OncoTargets and Therapy 2008:1 2
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tumor with those of the “wait and see” group, and matched 
both these results with recent international literature reviews 
(Berlin et al 2002; Bisson et al 2002; Lalla et al 2003).
In accordance with statistical data from international 
literature and on the basis of the margin involvement (lateral 
or deep), we divided the incompletely excised tumors into 
two subgroups (Figure. 1). Collaboration with the histolo-
gist in our section helped us introduce two further concepts: 
“focal involvement” of the tumor margin and tumor “in close 
proximity” to the margin of excision.
The former included the involvement of a portion of 
the lateral or deep margin, recording precisely the position, 
using a watch orientation. The latter concept meant margin 
involvement at less than 1 mm.
Moreover we evaluated the presence of residual tumor 
cells at the histological review.
During this study period we operated on 982 patients 
with basal cell carcinoma; 866 were reported as completely 
excised, of which 40 were in close proximity (less than 1 mm 
from the free margin of the tumor), while 116 had margin 
involvement.
Although re-excision was the treatment of choice, and 
our current practice for incompletely excised tumor, during 
the period examined only 36 patients out of 116 with margin 
involvement proceeded to re-excision. Of the remaining 80 
patients just 39 were followed up from the “wait and see” 
group. The loss of patients was due to advanced age, poor 
general conditions, and unavailability of transport facilities.
Results
In our statistical investigation only one of the 40 patients with 
residual tumor in close proximity (less than 1 mm), reported 
a recurrence during 8 years of follow-up.
Of the 36 patients who proceeded to further re-excision, 
26 (72%) revealed residual tumor.
In particular, of the 11 patients re-excised with focal margin 
involvement, 6 showed residual tumor in the specimen; of 
the 25 patients with lateral and deep margin involvement, 20 
contained residual tumor at histological review (Figure 2).
All these patients were re-excised within a period of 
4 weeks from the diagnosis; the pathology report and the 
surgical margin of visually normal skin was 2–3 mm.
The “wait and see” group showed 16 recurrences out 
of 39 patients (41%) during 8 years of follow-up; a sig-
niﬁ  cant number of recurrences was observed after 5 years 
of follow-up (6 out of 16 cases = 37,5% with deep margin 
involvement; Figure 3).
However it is necessary to point out that only 39 of 80 
patients (the “wait and see” group) were kept under observa-
tion with continuous follow-up.
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Discussion
The purpose of our study was to evaluate:
•  How many patients among the 40 “in close proximity” 
developed recurrent disease;
•  How many patients among the 36 re-excised showed 
residual tumor at histological review;
•  How many patients among the “wait and see” group 
developed recurrent disease;
•  Duration of follow-up.
Among the 40 patients with tumor “in close proximity” 
(less than 1 mm), only one showed a recurrence after 6 years 
of follow-up.
In this particular case, the tumor involved the inner 
canthus, where there is usually a high rate of recurrence 
(Shanoff et al 1967).
Grifﬁ  ths (1999) examined all re-excised BCC specimens 
from lesions with incompletely excised margins at ﬁ  rst sur-
gery, to establish the percentage of residual tumor cells at 
histological review. He found that 54% of scar specimens 
showed residual tumor upon histological examination, while 
our investigation reported 72%.
Our data collected from the “wait and see” group showed 
41% of recurrences, over a maximum period of 8 years of 
follow-up, in accordance with international literature (Rowe 
et al 1989; Grifﬁ  ths 1999).
In contrast with previous literature (Silverman et al 1992), 
which advocated as sufﬁ  cient a maximum period of 5 years 
of follow-up, we reported recurrences even after 5 years.
The 5-year probability of tumor recurrence was reported 
in the literature as 17% when the lateral margin was involved, 
and 33% for the deep margin (Liu et al 1991).
In conclusion, the clear margin of the histological 
specimen, including those “in close proximity”, repre-
sented a safe index for remaining relapse free, while margin 
involvement (including focal involvement), exposed a 
significant risk of recurrence and justified immediate 
re-excision.
This re-excision must be performed as soon as possible in order 
to avoid an incorrect diagnosis between recurrence and scar.
Koplin and Zarem (1980) recommended immediate re-
excision of all lesions with positive margins as soon as the 
wounds were adequately healed.
We therefore recommend, in accordance with Koplin 
and Zarem (1980), immediate re-excision of all lesions with 
positive margins.
These criteria are conﬁ  rmed by some investigators, who 
found a recurrence rate as high as 67% without distinguishing 
between lateral and deep margin (Shanoff et al 1967).
Other authors (Liu et al 1991) showed that of the “wait 
and see” group, only a minority of patients with incompletely 
excised BCC developed recurrent disease, where the follow-
up was continuous and diligent. In this case they performed 
a re-excision only on patients with clinical evidence of 
recurrent disease.
In our experience we had remarkable difﬁ  culty in main-
taining a diligent follow-up, due to poor attendance, mainly 
as a result of advanced age, poor general conditions, and lack 
of transport facilities.
We also experienced difﬁ  culty in discriminating between 
scar and tumor.
Conclusion
The statistical data of our retrospective study have strength-
ened our belief that histologically incomplete BCC should 
be re-excised.
The essential points that conﬁ  rm this belief are:
A.  The high number of residual tumors at histological review 
(72%);
B. Difﬁ  culty in maintaining diligent follow-up;
C.  Possibility of ﬁ  nding recurrence after 5 years of follow-up 
(in particular on the deep margin);
D. The need for more destructive surgery, than immediate 
re-excision;
E. Possible diagnostic error between recurrence and 
scar;
F.  It is important to note that the percentage of recur-
rence in the “wait and see” group (41%), in accordance 
with the international literature (Dellon et al 1985), 
was obtained on the basis of a low number of checks 
(39 out of 80 patients with regular follow-up), owing 
to the problem mentioned in point two. Moreover 
we observed that a clear margin in the histological 
specimen, including those “in close proximity”, 
represented a safe index of remaining relapse free, 
while margin involvement (including focal), exposed 
a significant risk of recurrence and justified immediate 
re-excision.
We therefore reserve a clinic follow-up only for patients 
whose poor general health dissuades us from re-operation.
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